col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Annals of Hepatology
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―08 COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem Pathum Sookaromdee, Viroj Wiwanitkit
2 [GO] 2021―Jun―10 Correspondence on “prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection” Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
3 [GO] 2021―Apr―30 COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis Mateo Porres-Aguilar, Alejandro Lazo-Langner, Arturo Panduro, Misael Uribe
4 [GO] 2021―Apr―24 Reply to: Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico Paulina Vidal-Cevallos, Fatima Higuera De-La-Tijera, Norberto C. Chávez-Tapia, Francisco Sanchez-Giron, Eira Cerda Reyes, Victor Hugo Rosales-Salyano, et al. (+3)
5 [GO] 2021―Apr―21 Characteristics and In-Hospital Outcomes of COVID-19 Patients with Abnormal Liver Biochemical Tests Yanyan Wu, Zhuang Ma, Xiaozhong Guo, Hongyu Li, Yufu Tang, Hao Meng, et al. (+13)
6 [GO] 2021―Apr―15 Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico Feiyan Zhu, Xiaofei Li
7 [GO] 2021―Apr―15 Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection Manuel Mendizabal, Ezequiel Ridruejo, Federico Piñero, Margarita Anders, Martín Padilla, Luis G. Toro, et al. (+39)
8 [GO] 2021―Feb―26 Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study Paulina Vidal-Cevallos, Fatima Higuera-De-La-Tijera, Norberto C. Chávez-Tapia, Francisco Sanchez-Giron, Eira Cerda Reyes, Victor Hugo Rosales-Salyano, et al. (+3)
9 [GO] 2021―Feb―23 Latin America and chronic diseases: A perfect storm during the COVID-19 pandemic Antonio Pizuorno, Nora A. Fierro
10 [GO] 2021―Feb―21 Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19 Amer Hamadé, Bastien Woehl, Marjolaine Talbot, Naouel Bensalah, Pierre Michel, Golnaz Obringer, et al. (+6)
11 [GO] 2021―Feb―11 Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19) Ivan López-Mendez, Graciela Castro-Narro
12 [GO] 2021―Jan―12 Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19 Xiangyu Zhu, Xiaofei Li
13 [GO] 2021―Jan―10 Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission Manuel Mendizabal, Federico Piñero, Ezequiel Ridruejo, Margarita Anders, María Dolores Silveyra, Aldo Torre, et al. (+35)
14 [GO] 2020―Dec―30 Viruses and the Liver 2020: Before COVID-19 and the beginning of a new age in medicine Arturo Panduro
15 [GO] 2020―Nov―27 Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19) Xiaofei Li
16 [GO] 2020―Nov―04 Prognostic value of liver biochemical parameters for COVID-19 mortality Lin Ye, Bin Chen, Yitong Wang, Yi Yang, Jiling Zeng, Guangtong Deng, et al. (+2)
17 [GO] 2020―Oct―31 Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19 Amer Hamadé, Bastien Woehl, Marjolaine Talbot, Naouel Bensalah, Pierre Michel, Golnaz Obringer, et al. (+6)
18 [GO] 2020―Oct―21 Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19) Ivan Lopez-Mendez, Jorge Aquino-Matus, Sofia Murua-Beltrán Gall, Jose D. Prieto-Nava, Eva Juarez-Hernandez, Misael Uribe, Graciela Castro-Narro
19 [GO] 2020―Oct―16 Liver disease and outcomes among COVID-19 hospitalized patients- a systematic review and meta-analysis Ashish Sharma, Pragya Jaiswal, Yasameen Kerakhan, Lakshmi Saravanan, Zeba Murtaza, Azka Zergham, et al. (+10)
20 [GO] 2020―Oct―11 Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases Faxiang Chen, Wei Chen, Jianpu Chen, Dan Xu, Wei Xie, Xiang Wang, Yuanliang Xie
21 [GO] 2020―Sep―18 COVID-19 and the liver: What do we know after six months of the pandemic? N.A. Fierro
22 [GO] 2020―Sep―14 Hepatic and gastrointestinal manifestations of SARS-COV-2 infection (COVID-19) J. Aquino-Matus, I. Lopez-Mendez, E. Juarez-Hernandez, S. Murua-Beltran Gall, J.D. Prieto-Nava, P. Castañeda-Mendez, et al. (+2)
23 [GO] 2020―Sep―14 Frequency and characteristics of alterations in liver function tests (LFT) in adult patients with COVID-19 (preliminary report) D. Menéndez-Morales, G.A. Peña-Arellano, M.S. González-Huezo
24 [GO] 2020―Sep―14 Acute liver injury and survival in patients with SARS-Cov-2 from the Hospital Central Militar A. Figueroa-Peña, N.A. Gómez-Bolaños, C. Monejo-Velázquez, E. Muñoz-Monroy, M. Santiago-Torres, S. Hernández-Díaz, et al. (+4)
25 [GO] 2020―Sep―10 The effect of liver test abnormalities on the prognosis of covid-19 Alpay Medetalibeyoglu, Yunus Catma, Naci Senkal, Asli Ormeci, Bilger Cavus, Murat Kose, et al. (+5)
26 [GO] 2020―Sep―02 Hepatology and the “new reality” ushered in by the COVID-19 pandemic Misael Uribe, Jorge Aquino-Matus
27 [GO] 2020―Aug―31 A systematic review and meta-analysis of the COVID-19 associated liver injury Yu-Jun Wong, Malcolm Tan, Qishi Zheng, Weiquan Li, Rahul Kumar, Kwong-Ming Fock, et al. (+2)
28 [GO] 2020―Aug―25 SARS-CoV-2 another kind of liver aggressor, how does it do that? Sonia A. Lozano-Sepulveda, Kame Galan-Huerta, Natalia Martínez-Acuña, Daniel Arellanos-Soto, Ana María Rivas-Estilla
29 [GO] 2020―May―23 Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology Marco Arrese
30 [GO] 2020―May―18 The liver in times of COVID-19: What hepatologists should know Ezequiel Ridruejo, Alejandro Soza


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.014 sec